NASDAQ:BDSX

Biodesix Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy BDSX

*Your capital is at risk

$16.10

+0.660 (+4.27%)

At Close: Jun 03, 2026

Biodesix Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 94.08. In total, the insiders bought 4.33M and sold 11.3K BDSX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	94.08
● Buy	4.33M shares
● Sell	11.3K shares
80% Buy Activity Weak Positive Correlation
Sell Signal Low Confidence Feb 23, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 94.08. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 09, 2026 Buy	Common Stock M-Exempt	O'kane Kieran Chief Commercial Officer	Officer	1 600 Value: $15.9K
Feb 09, 2026 Buy	Restricted Stock Units M-Exempt	O'kane Kieran Chief Commercial Officer	Officer	1 527 Value: $15.2K
Feb 09, 2026 Buy	Restricted Stock Units M-Exempt	Vazquez Chris Chief Accounting Officer	Officer	28 Value: $278
Feb 09, 2026 Buy	Common Stock M-Exempt	Hutton Scott President & CEO	CEO / President	9 998 Value: $99.3K
Feb 09, 2026 Buy	Restricted Stock Units M-Exempt	Hutton Scott President & CEO	CEO / President	9 388 Value: $93.2K
Feb 09, 2026 Buy	Restricted Stock Units M-Exempt	Hutton Scott President & CEO	CEO / President	610 Value: $6K
Feb 09, 2026 Buy	Common Stock M-Exempt	Cowie Robin Harper CFO, Sec'y & Treasurer	C-Suite Officer	2 584 Value: $25.7K
Feb 09, 2026 Buy	Restricted Stock Units M-Exempt	Cowie Robin Harper CFO, Sec'y & Treasurer	C-Suite Officer	2 427 Value: $24.1K
Feb 09, 2026 Buy	Restricted Stock Units M-Exempt	Cowie Robin Harper CFO, Sec'y & Treasurer	C-Suite Officer	157 Value: $2K
Feb 09, 2026 Buy	Common Stock M-Exempt	Pestano Gary Anthony Chief Development Officer	Officer	1 481 Value: $14.7K
Feb 09, 2026 Buy	Restricted Stock Units M-Exempt	Pestano Gary Anthony Chief Development Officer	Officer	1 413 Value: $14.0K
Feb 09, 2026 Buy	Restricted Stock Units M-Exempt	Pestano Gary Anthony Chief Development Officer	Officer	68 Value: $675
Jan 26, 2026 Buy	Common Stock P-Purchase	Schuler Jack W Emeritus Director	Director	20 000 Value: $236.1K
Jan 23, 2026 Buy	Common Stock P-Purchase	Schuler Jack W Emeritus Director	Director	80 000 Value: $944.7K
Jan 22, 2026 Buy	Common Stock P-Purchase	Schuler Jack W Emeritus Director	Director	82 465 Value: $903.6K
Jan 16, 2026 Sell	Common Stock S-Sale	Cowie Robin Harper CFO, Sec'y & Treasurer	C-Suite Officer	298 Value: $2K
Jan 16, 2026 Sell	Common Stock S-Sale	Hutton Scott President & CEO	CEO / President	970 Value: $8K
Jan 16, 2026 Sell	Common Stock S-Sale	O'kane Kieran Chief Commercial Officer	Officer	298 Value: $2K
Jan 16, 2026 Sell	Common Stock S-Sale	Vazquez Chris Chief Accounting Officer	Officer	83 Value: $676
Jan 16, 2026 Sell	Common Stock S-Sale	Pestano Gary Anthony Chief Development Officer	Officer	298 Value: $2K
Jan 15, 2026 Buy	Restricted Stock Units M-Exempt	Cowie Robin Harper CFO, Sec'y & Treasurer	C-Suite Officer	805 Value: $7K
Jan 15, 2026 Buy	Common Stock M-Exempt	Cowie Robin Harper CFO, Sec'y & Treasurer	C-Suite Officer	805 Value: $7K
Jan 15, 2026 Buy	Restricted Stock Units M-Exempt	Hutton Scott President & CEO	CEO / President	2 633 Value: $21.9K
Jan 15, 2026 Buy	Common Stock M-Exempt	Hutton Scott President & CEO	CEO / President	2 633 Value: $21.9K
Jan 15, 2026 Buy	Restricted Stock Units M-Exempt	O'kane Kieran Chief Commercial Officer	Officer	805 Value: $7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BIODESIX INC

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. ...

Read Full Profile Here